263 related articles for article (PubMed ID: 7449380)
1. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
2. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
[TBL] [Abstract][Full Text] [Related]
3. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
Ballard CA
Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
[TBL] [Abstract][Full Text] [Related]
4. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
[TBL] [Abstract][Full Text] [Related]
5. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.
Moberg PJ; Bygdeman M; Carnsjö LG; Frankman O; Gréen K
Acta Obstet Gynecol Scand Suppl; 1983; 113():137-40. PubMed ID: 6574668
[TBL] [Abstract][Full Text] [Related]
6. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different prostaglandin analogues and laminaria for preoperative dilatation of the cervix in late first trimester abortion.
Christensen NJ; Bygdeman M; Gréen K
Contraception; 1983 Jan; 27(1):51-61. PubMed ID: 6839758
[TBL] [Abstract][Full Text] [Related]
8. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
[TBL] [Abstract][Full Text] [Related]
9. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
Shapiro AG; Lasseter K; Cobiella A; Domenzain M
Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
[TBL] [Abstract][Full Text] [Related]
10. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
Karim SM; Choo HT; Cheng P
Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
[TBL] [Abstract][Full Text] [Related]
11. Abortifacient effect and uterine cervix-dilating action of 16, 16-dimethyl trans delta 2 PGE1 methyl ester (ONO 802) in the form of a vaginal suppository (a randomized, double-blind, controlled study in the second trimester of pregnancy).
Sakamoto S; Satoh K; Nishiya I; Kunimoto K; Chimura T; Oda T; Takeuchi S; Satoh Y; Iizuka R; Kobayashi T; Takagi S; Yoshida T; Tomoda Y; Ninagawa T; Kurachi K; Tanizawa O; Tojo S; Mochizuki M; Maeda K; Tominaga Y; Torigoe T; Koresawa M; Taki I; Hamada T
Prostaglandins Leukot Med; 1982 Sep; 9(3):349-61. PubMed ID: 6752961
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 induction of abortion and fetal demise.
Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
[TBL] [Abstract][Full Text] [Related]
13. Cervical priming prior to dilatation and evacuation: a comparison of methods.
Lauersen NH; Den T; Iliescu C; Wilson KH; Graves ZR
Am J Obstet Gynecol; 1982 Dec; 144(8):890-4. PubMed ID: 7148920
[TBL] [Abstract][Full Text] [Related]
14. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
Somell C; Olund A
Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
[TBL] [Abstract][Full Text] [Related]
15. Cervical dilatation with 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (Cervagem) prior to vacuum aspiration. A double-blind, placebo-controlled randomized study.
Christensen NJ; Bygdeman M
Contraception; 1984 May; 29(5):457-64. PubMed ID: 6378517
[TBL] [Abstract][Full Text] [Related]
16. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
Lauersen NH; Wilson KH
Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
[TBL] [Abstract][Full Text] [Related]
17. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
Bolognese RJ; Corson SL
Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
[TBL] [Abstract][Full Text] [Related]
18. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
Wagatsuma T; Tabuchi T; Tabei T; Kaku R
Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester termination with 16,16 dimethyl-PGE1-methyl ester (gemeprost), compared with a regimen that included intra-amniotic PGF2 alpha and hypertonic saline.
Waldron KW; Renou PM; Lolatgis N; Morris ND; Mamers PM; Oldham J; Healy DL
Reprod Fertil Dev; 1990; 2(5):495-8. PubMed ID: 2075246
[TBL] [Abstract][Full Text] [Related]
20. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
